₹6.94
₹-0.13 (-1.84%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹35 Cr
P/E
-2.12
ROE
-26.30%
ROCE
-22.21%
About Lasa Supergenerics Ltd
Lasa Supergenerics is primarily engaged in the business of manufacturing API bulk drugs products.
Founded
2016
CEO
Omkar P Herlekar
Employees
66
HQ
Mumbai, India
About Lasa Supergenerics Ltd
Lasa Supergenerics is primarily engaged in the business of manufacturing API bulk drugs products.
Founded:2016
CEO:Omkar P Herlekar
Employees:66
HQ:Mumbai, India
Finished Products
1Sale of Products
₹246.78CrRaw Materials
1Raw Material Consumed
₹187.38CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹14
52W Low
₹6
Volume20.76K
Avg VolumeN/A
Beta0.86
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-2.12x
Valuation
P/B Ratio
0.71x
Valuation
EPS
₹-3.30
Valuation
Dividend Yield
0.00%
Valuation
ROE
-26.30%
Profitability
ROCE
-22.21%
Profitability
Revenue by Segment
Contribution & growth by business line
Active Pharmaceutical IngredientsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.20x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.